SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-219046
Filing Date
2019-08-12
Accepted
2019-08-12 16:31:55
Documents
32
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d747883d10q.htm 10-Q 243168
2 EX-31.1 d747883dex311.htm EX-31.1 6320
3 EX-31.2 d747883dex312.htm EX-31.2 6323
4 EX-32.1 d747883dex321.htm EX-32.1 2858
5 EX-32.2 d747883dex322.htm EX-32.2 2937
  Complete submission text file 0001193125-19-219046.txt   1527312

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20190630.xml EX-101.INS 228850
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20190630.xsd EX-101.SCH 18455
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20190630_cal.xml EX-101.CAL 15701
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20190630_def.xml EX-101.DEF 95917
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20190630_lab.xml EX-101.LAB 162497
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20190630_pre.xml EX-101.PRE 127447
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 191016895
SIC: 8731 Services-Commercial Physical & Biological Research